Sugammadex Injection, Solution
Product Images NDC 72205-478

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 72205-478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sugammadex-200mg-2ml-carton (Sugammadex 200mg 2ml Carton)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous injection. This label set is for 10 single-dose vials of 2 mL each. The product is distributed by Novadoz Pharmaceuticals LLC and manufactured by MSN Laboratories Private Limited. The label includes storage information and dosage form details.*

FDA Label Image

Sugammadex-200mg-2ml-vial (Sugammadex 200mg 2ml Vial)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) single-dose vial for intravenous use. The label includes storage instructions to store at 25°C and protect from light. Distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. The label also has a peel-off section indicating Sugammadex Injection at 100 mg/mL concentration for syringe application.*

FDA Label Image

Sugammadex-500mg-5ml-carton (Sugammadex 500mg 5ml Carton)

Packaging label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) solution for intravenous use. The carton contains 10 single-dose vials of 5 mL each. The labeler is Novadoz Pharmaceuticals LLC. The label includes storage conditions, dosage form, and manufacturer information for MSN Laboratories Private Limited, India.*

FDA Label Image

Sugammadex-500mg-5ml-vial (Sugammadex 500mg 5ml Vial)

Label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) single-dose vial by Novadoz Pharmaceuticals LLC. The label states use is for intravenous injection only and provides storage instructions and dosage information. It includes a barcode and a peel-off section for syringe application with dosage recording.*

FDA Label Image

Sugammadex-figure-1 (Sugammadex Figure 1)

A cumulative recovery rate chart comparing the time to recovery in minutes for Sugammadex 2 mg/kg and Neostigmine 0.05 mg/kg. The y-axis represents cumulative recovery rate from 0 to 1.0, and the x-axis shows time to recovery ranging from 0 to 120 minutes. Sugammadex shows a faster recovery with a median time of 1.4 minutes, while Neostigmine has a slower recovery with a median time of 21.5 minutes, as indicated in the inset table.*

FDA Label Image

Sugammadex-figure-2 (Sugammadex Figure 2)

A cumulative recovery rate graph comparing recovery times between sugammadex 2 mg/kg and neostigmine 0.05 mg/kg after vecuronium administration. The x-axis represents time to recovery in minutes (0 to 120), and the y-axis shows the cumulative recovery rate (0.0 to 1.0). Sugammadex demonstrates a faster recovery rate, reaching nearly 1.0 at around 10 minutes, while neostigmine shows a slower, gradual increase up to approximately 0.75 by 120 minutes.*

FDA Label Image

Sugammadex-structure-1 (Sugammadex Structure 1)

Chemical structure of Sugammadex, depicting its complex molecular arrangement as shown in the diagram.*

FDA Label Image

Sugammadex-structure-2 (Sugammadex Structure 2)

Chemical structure diagram depicting the molecular composition of Sugammadex, showing its cyclic framework with multiple functional groups including hydroxyls and carboxylates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.